United Therapeutics (UTHR) Misses Q1 EPS by 117c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $497.27 -0.24%
Revenue Growth %: -1.2%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -1.2%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.82, $1.17 worse than the analyst estimate of $6.99. Revenue for the quarter came in at $781.5 million versus the consensus estimate of $798.85 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Sadot Group names Michael Murray as CEO and CFO
- Rexford Industrial closes $1.2B portfolio sale to EQT Real Estate
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
